United Pharmaceutical Establishment
United Pharmaceutical Establishment, commonly referred to as UPE, is a leading player in the pharmaceutical industry, headquartered in Saudi Arabia (SA). Established in 1993, UPE has made significant strides in the development and distribution of high-quality pharmaceutical products across the Middle East and North Africa (MENA) region. Specialising in a diverse range of therapeutic areas, UPE is renowned for its innovative formulations and commitment to quality. The company’s core offerings include prescription medications, over-the-counter products, and specialised healthcare solutions, all designed to meet the evolving needs of patients and healthcare providers. With a strong market presence and a reputation for excellence, United Pharmaceutical Establishment has achieved numerous accolades, solidifying its position as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does United Pharmaceutical Establishment's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
United Pharmaceutical Establishment's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
United Pharmaceutical Establishment's reported carbon emissions
United Pharmaceutical Establishment, headquartered in Saudi Arabia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. This lack of data suggests that United Pharmaceutical Establishment may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
United Pharmaceutical Establishment is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
